| |
Home »
News » 02/06
» GlaxoSmithKline Arixtra found effective
GlaxoSmithKline Arixtra found effective
Date published: 15/02/2006
Studies
of the GlaxoSmithKline (GSK) drug Arixtra (fondaparinux sodium) have found it
to be effective. Artemis (Arixtra for Thromboembolism prevention in a Medical
Indications Study) found the treatment reduced the risk of venous
thromboembolism (VTE) by 46.7 per cent.
Dr Alexander Cohen, of King's
College Hospital London and chairman of the Artemis steering committee, said:
"VTE presents a significant risk to this patient population, however we have
had limited understanding of the effectiveness of clot prevention to address
VTE in this group. "These results show that Arixtra is an effective and well
tolerated treatment that can reduce the risk of VTE for these patients, further
helping us to define the role of anti-thrombotics in this setting." Dr Lawson
Macartney, of GSK, added: "GSK is excited about these results that support
Arixtra in the treatment of this population, and may help to expand the
application of Arixtra in clinical practice."
Arixtra was also found not
to increase the risk of major bleeding in patients. It is currently approved
for use in the European Union for the prevention of VTE in patients undergoing
surgery for hip fracture, knee replacement, hip replacement and those at high
risk of thromboembolic complications. It also indicated for the treatment of
acute deep vein thrombosis and the treatment of acute pulmonary embolism.
© Adfero Ltd
Disclaimer
AllAboutMedicalSales excludes any warranty, express or implied, as to
the quality, accuracy, timeliness, completeness or fitness for a particular
purpose of this briefing. AllAboutMedicalSales will not be liable for any
claims, penalties, losses, damages, costs, or expenses arising from the use of
or inability to use this briefing or from any unauthorised access to or
alteration of the Briefing. AllAboutMedicalSales makes no warranty that the
contents of this briefing are compatible with all computer systems and
browsers.
|
